Evaluating gliclazide for the treatment of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating gliclazide for the treatment of type 2 diabetes mellitus

Published:2022-11-10 Issue:17 Volume:23 Page:1869-1877
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Tomlinson Brian¹^ORCID,Li Yan-Hong²^ORCID,Chan Paul³^ORCID

Affiliation:

1. Faculty of Medicine, Macau University of Science and Technology, Macau, China

2. The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, China

3. Division of Cardiovascular Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan

Funder

This work was funded by faculty research funding from the Faculty of Medicine, Macau University of Science and Technology

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2141108

Reference84 articles.

1. Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes

2. Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes

3. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

4. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022

5. Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second‐line therapy after metformin monotherapy: R etrospective data for 10 256 individuals from the U nited K ingdom and G ermany

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential of signature-based drug repurposing for anticancer drug discovery;Archives of Biochemistry and Biophysics;2024-11

2. Evaluating Gliclazide Safety and Effectiveness in the Management of Type 2 Diabetes Mellitus;International Journal of Innovative Science and Research Technology (IJISRT);2024-07-12

3. Development, characterization, and evaluation of polymer-based hydrogel membrane patches for intestinal delivery of gliclazide;Polymer-Plastics Technology and Materials;2024-05-31

4. Gliclazide Ameliorates Neuronal Injury by Attenuating Oxidative Stress in D-gal-Induced Senescent Cells and Aging Mice;Molecular Neurobiology;2023-12-13

5. Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit;Advances in Therapy;2023-05-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3